Drug Patents owned by Titan Pharms
1. Drug name - PROBUPHINE
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7736665 | TITAN PHARMS | Implantable polymeric device for sustained release of buprenorphine |
Apr, 2024
(1 year, 6 months from now) | |
Drugs and Companies using BUPRENORPHINE HYDROCHLORIDE ingredient
Treatment: For opioid dependence
Dosage: IMPLANT;IMPLANTATION
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| EQ 80MG BASE/IMPLANT | IMPLANT;IMPLANTATION | Discontinued |
availability in other generic markets.
Click on the highlighted region to filter.